Genetic variants in the catechol-o-methyltransferase gene are associated with impulsivity and executive function: Relevance for major depression

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 8, 2012, Pages 928-940

  Pap, Dorottya ^a   Gonda, Xenia ^a   Molnar, Eszter ^a   Lazary, Judit ^a   Benko, Anita ^a   Downey, Darragh ^b   Thomas, Emma ^b   Chase, Diana ^b   Toth, Zoltan G ^c,d   Mekli, Krisztina ^b   Platt, Hazel ^b   Payton, Antony ^b   Elliott, Rebecca ^b   Anderson, Ian M ^b   Deakin, J F William ^b   Bagdy, Gyorgy ^a   Juhasz, Gabriella ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ÓBUDA UNIVERSITY   (Hungary)

Author keywords

Cognition; COMT; Depression; Haplotype; Intermediate phenotype; Modelling

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPULSIVENESS; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURAL EQUATION MODELING;

ADOLESCENT; ADULT; ANXIETY DISORDERS; CATECHOL O-METHYLTRANSFERASE; DEPRESSIVE DISORDER, MAJOR; EXECUTIVE FUNCTION; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; MOUTH MUCOSA; NEUROTIC DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84869015888     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32098     Document Type: Article

References (84)

1. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. 2003. Catechol-o-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23(6): 2008- 2013.
2. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. 2003. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 6(2): 115- 116.
3. Barnett JH, Heron J, Goldman D, Jones PB, Xu K. 2009. Effects of catechol-o-methyltransferase on normal variation in the cognitive function of children. Am J Psychiatr 166(8): 909- 916.
4. Barrett JH. 2002. Association studies. Method Mol Biol 195: 3- 12.
5. Benko A, Lazary J, Molnar E, Gonda X, Tothfalusi L, Pap D, Mirnics Z, Kurimay T, Chase D, Juhasz G, et al. 2009. Significant association between the C (-1019) G functional polymorphism of the HTR1A gene and impulsivity. Am J Med Genet B 153B(2): 592- 599.
6. Bezdjian S, Baker LA, Tuvblad C. 2011. Genetic and environmental influences on impulsivity: A meta-analysis of twin, family and adoption studies. Clin Psychol Rev 31(7): 1209- 1223.
7. Bickel WK, Jarmolowicz DP, Mueller ET, Gatchalian KM, McClure SM. 2012. Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction. Psychopharmacol Berl 221(3): 361- 387.
8. Bilder RM, Volavka J, Lachman HM, Grace AA. 2004. The catechol-o-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29(11): 1943- 1961.
9. Biringer E, Lundervold A, Stordal K, Mykletun A, Egeland J, Bottlender R, Lund A. 2005. Executive function improvement upon remission of recurrent unipolar depression. Eur Arch Psychiat Clin Neurosci 255(6): 373- 380.
10. Boettiger CA, Mitchell JM, Tavares VC, Robertson M, Joslyn G, D'Esposito M, Fields HL. 2007. Immediate reward bias in humans: Fronto-parietal networks and a role for the catechol-o-methyltransferase 158 (Val/Val) genotype. J Neurosci 27(52): 14383- 14391.
11. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, O'Donovan MC. 2003. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73(1): 152- 161.
12. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, et al. 2010. Dopaminergic network differences in human impulsivity. Science 329(5991): 532.
13. Byrne B. 2001. Structural equation modeling with AMOS, basic concepts, applications, and programming. Mahwah, NJ: Lawrence Erlbaum Associates.
14. Cataldo MG, Nobile M, Lorusso ML, Battaglia M, Molteni M. 2005. Impulsivity in depressed children and adolescents: A comparison between behavioral and neuropsychological data. Psychiat Res 136(2-3): 123- 133.
15. Cazalis F, Valabregue R, Pelegrini-Issac M, Asloun S, Robbins TW, Granon S. 2003. Individual differences in prefrontal cortical activation on the tower of London planning task: Implication for effortful processing. Eur J Neurosci 17(10): 2219- 2225.
16. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, et al. 2004. Functional analysis of genetic variation in catechol-o-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75(5): 807- 821.
17. Clark L, Chamberlain SR, Sahakian BJ. 2009. Neurocognitive mechanisms in depression: Implications for treatment. Annu Rev Neurosci 32: 57- 74.
18. Colzato LS, van den Wildenberg WP, Van der Does AJ, Hommel B. 2010. Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 170(3): 782- 788.
19. Congdon E, Canli T. 2008. A neurogenetic approach to impulsivity. J Pers 76(6): 1447- 1484.
20. Cools R, D'Esposito M. 2011. Inverted-u-shaped dopamine actions on human working memory and cognitive control. Biol Psychiat 69(12): e113- e125.
21. Corruble E, Benyamina A, Bayle F, Falissard B, Hardy P. 2003. Understanding impulsivity in severe depression? A psychometrical contribution. Prog Neuropsychopharmacol Biol Psychiat 27(5): 829- 833.
22. Corruble E, Damy C, Guelfi JD. 1999. Impulsivity: A relevant dimension in depression regarding suicide attempts? J Affect Disord 53(3): 211- 215.
23. Costa PT Jr, McCrae RR. 1992. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) professional manual. Odessa, FL: Psychological Assessment Resources.
24. Craddock N, Owen MJ, O'Donovan MC. 2006. The catechol-o-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: Evidence and lessons. Mol Psychiat 11(5): 446- 458.
25. Deakin JF. 2003. Depression and antisocial personality disorder: Two contrasting disorders of 5HT function. J Neural Transm Suppl (64): 79- 93.
26. Derogatis LR, Melisaratos N. 1983. The brief symptom inventory: An introductory report. Psychol Med 13(3): 595- 605.
27. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR. 2006. Catechol-o-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiat 63(12): 1396- 1406.
28. Eagle DM, Baunez C, Hutcheson DM, Lehmann O, Shah AP, Robbins TW. 2008. Stop-signal reactiontime task performance: Role of prefrontal cortex and subthalamic nucleus. Cereb Cortex 18(1): 178- 188.
29. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98(12): 6917- 6922.
30. Elliott R, Zahn R, Deakin JF, Anderson IM. 2011. Affective cognition and its disruption in mood disorders. Neuropsychopharmacology 36(1): 153- 182.
31. Eysenck SBG, Eysenck HJ. 1978. Impulsiveness and venturesomeness: Their position in a dimensional system of personality description. Psychol Rep 43: 1247- 1255.
32. First MB SRL, Gibbon M, Williams JBW. 2002. Structured clinical interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York: State Psychiatric Institute Biometrics Research Department.
33. Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW. 2003. DNA from buccal swabs recruited by mail: Evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet 33(1): 67- 72.
34. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M., et al. 2002. The structure of haplotype blocks in the human genome. Science 296(5576): 2225- 2229.
35. Goldman-Rakic PS, Muly EC III, Williams GV. 2000. D (1) receptors in prefrontal cells and circuits. Brain Res Rev 31(2-3): 295- 301.
36. Grano N, Keltikangas-Jarvinen L, Kouvonen A, Virtanen M, Elovainio M, Vahtera J, Kivimaki M. 2007. Impulsivity as a predictor of newly diagnosed depression. Scand J Psychol 48(2): 173- 179.
37. Halleland H, Lundervold AJ, Halmoy A, Haavik J, Johansson S. 2009. Association between catechol-o-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults. Am J Med Genet B Neuropsychiat Genet 150B(3): 403- 410.
38. Horn NR, Dolan M, Elliott R, Deakin JF, Woodruff PW. 2003. Response inhibition and impulsivity: An fMRI study. Neuropsychologia 41(14): 1959- 1966.
39. John OP, Srivastava S. 1999. The big five trait taxonomy: History, measurement, and theoretical perspectives. In: Pervin LA, John OP, (Eds.), Handbook of personality: Theory and research, 2nd edition. New York: Guilford Press. 102- 139.
40. Johnstone T, van Reekum CM, Urry HL, Kalin NH, Davidson RJ. 2007. Failure to regulate: Counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J Neurosci 27(33): 8877- 8884.
41. Juhasz G, Chase D, Pegg E, Downey D, Toth ZG, Stones K, Platt H, Mekli K, Payton A, Elliott R., et al. 2009a. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 34(8): 2019- 2027.
42. Juhasz G, Downey D, Hinvest N, Thomas E, Chase D, Toth ZG, Lloyd-Williams K, Mekli K, Platt H, Payton A, et al. 2010. Risk-taking behavior in a gambling task associated with variations in the tryptophan hydroxylase 2 gene: Relevance to psychiatric disorders. Neuropsychopharmacology 35(5): 1109- 1119.
43. Juhasz G, Dunham JS, McKie S, Thomas E, Downey D, Chase D, Lloyd-Williams K, Toth ZG, Platt H, Mekli K., et al. 2011. The CREB1-BDNF-NTRK2 pathway in depression: Multiple gene-cognition-environment interactions. Biol Psychiat 69(8): 762- 771.
44. Juhasz G, Lazary J, Chase D, Pegg E, Downey D, Toth ZG, Stones K, Platt H, Mekli K, Payton A, et al. 2009b. Variations in the cannabinoid receptor 1 gene predispose to migraine. Neurosci Lett 461(2): 116- 120.
45. Kirby KN, Finch JC. 2010. The hierarchical structure of self-reported impulsivity. Pers Individ Differ 48(6): 704- 713.
46. Logan GDCW, Davis KA. 1984. On the ability to inhibit simple and choice reaction time responses: A model and a method. J Exp Psychol Hum Percept Perform 10(2): 276- 291.
47. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J. 1995. Kinetics of human soluble and membrane-bound catechol o-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34(13): 4202- 4210.
48. Mann JJ. 1999. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21(2 Suppl): 99S- 105S.
49. Mekli K, Payton A, Miyajima F, Platt H, Thomas E, Downey D, Lloyd-Williams K, Chase D, Toth ZG, Elliott R, et al. 2010. The HTR1A and HTR1B receptor genes influence stress-related information processing. Eur Neuropsychopharmacol 21(1): 129- 139.
50. Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, Nussbaum R, Weinberger DR, Berman KF. 2005. Midbrain dopamine and prefrontal function in humans: Interaction and modulation by COMT genotype. Nat Neurosci 8(5): 594- 596.
51. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, Mattay VS, Egan M, Weinberger DR. 2006. Impact of complex genetic variation in COMT on human brain function. Mol Psychiat 11(9): 867- 877; 797.
52. Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7(10): 818- 827.
53. Mier D, Kirsch P, Meyer-Lindenberg A. 2010. Neural substrates of pleiotropic action of genetic variation in COMT: A meta-analysis. Mol Psychiat 15(9): 918- 927.
54. Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiat 134: 382- 389.
55. Mukherjee N, Kidd KK, Pakstis AJ, Speed WC, Li H, Tarnok Z, Barta C, Kajuna SL, Kidd JR. 2008. The complex global pattern of genetic variation and linkage disequilibrium at catechol-o-methyltransferase. Mol Psychiat 15(2): 216- 225.
56. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L. 2006. Human catechol-o-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314(5807): 1930- 1933.
57. Niendam TA, Laird AR, Ray KL, Dean YM, Glahn DC, Carter CS. 2012. Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions. Cogn Affect Behav Neurosci 12(2): 241- 268.
58. Nolan KA, Bilder RM, Lachman HM, Volavka J. 2004. Catechol o-methyltransferase Val158Met polymorphism in schizophrenia: Differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiat 161(2): 359- 361.
59. Nolan KA, D'Angelo D, Hoptman MJ. 2010a. Self-report and laboratory measures of impulsivity in patients with schizophrenia or schizoaffective disorder and healthy controls. Psychiat Res 187(1-2): 301- 303.
60. Nolan KA, D'Angelo D, Hoptman MJ. 2010b. Self-report and laboratory measures of impulsivity in patients with schizophrenia or schizoaffective disorder and healthy controls. Psychiat Res 187(1-2): 301- 303.
61. Opmeer EM, Kortekaas R, Aleman A. 2010. Depression and the role of genes involved in dopamine metabolism and signalling. Prog Neurobiol 92(2): 112- 133.
62. Paloyelis Y, Asherson P, Mehta MA, Faraone SV, Kuntsi J. 2010. DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls. Neuropsychopharmacology 35(12): 2414- 2426.
63. Pattij T, Vanderschuren LJ. 2008. The neuropharmacology of impulsive behavior. Trend Pharmacol Sci 29(4): 192- 199.
64. Peluso MA, Hatch JP, Glahn DC, Monkul ES, Sanches M, Najt P, Bowden CL, Barratt ES, Soares JC. 2007. Trait impulsivity in patients with mood disorders. J Affect Disord 100(1-3): 227- 231.
65. Peters J, Buchel C. 2011. The neural mechanisms of inter-temporal decision-making: Understanding variability. Trend Cogn Sci 15(5): 227- 239.
66. Pezawas L, Stamenkovic M, Jagsch R, Ackerl S, Putz C, Stelzer B, Moffat RR, Schindler S, Aschauer H, Kasper S. 2002. A longitudinal view of triggers and thresholds of suicidal behavior in depression. J Clin Psychiat 63(10): 866- 873.
67. Phillips ML, Ladouceur CD, Drevets WC. 2008. A neural model of voluntary and automatic emotion regulation: Implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiat 13(9): 829; 833-57.
68. Rosa EC, Dickinson D, Apud J, Weinberger DR, Elvevag B. 2010. COMT Val158Met polymorphism, cognitive stability and cognitive flexibility: An experimental examination. Behav Brain Funct 6: 53.
69. Roussos P, Giakoumaki SG, Pavlakis S, Bitsios P. 2008. Planning, decision-making and the COMT rs4818 polymorphism in healthy males. Neuropsychologia 46(2): 757- 763.
70. Sawaguchi T. 2000. The role of D1-dopamine receptors in working memory-guided movements mediated by frontal cortical areas. Parkinsonism Relat Disord 7(1): 9- 19.
71. Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Buchel C, Conrod PJ, Dalley JW, Flor H, Gallinat J, et al. 2010. The IMAGEN study: Reinforcement-related behavior in normal brain function and psychopathology. Mol Psychiat 15(12): 1128- 1139.
72. Sen S, Burmeister M, Ghosh D. 2004. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B 127B(1): 85- 89.
73. Serretti A, Rotondo A, Lorenzi C, Smeraldi E, Cassano GB. 2006. Catechol-o-methyltransferase gene variants in mood disorders in the Italian population. Psychiat Genet 16(5): 181- 182.
74. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N, Edenberg HJ, Nurnberger JI Jr, Rietschel M, Blackwood D, et al. 2011. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43(10): 977- 983.
75. Smolka MN, Schumann G, Wrase J, Grusser SM, Flor H, Mann K, Braus DF, Goldman D, Buchel C, Heinz A. 2005. Catechol-o-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 25(4): 836- 842.
76. Strakowski SM, Fleck DE, DelBello MP, Adler CM, Shear PK, Kotwal R, Arndt S. 2010. Impulsivity across the course of bipolar disorder. Bipolar Disord 12(3): 285- 297.
77. Swann AC, Steinberg JL, Lijffijt M, Moeller FG. 2008. Impulsivity: Differential relationship to depression and mania in bipolar disorder. J Affect Disord 106(3): 241- 248.
78. Tunbridge EM, Harrison PJ, Weinberger DR. 2006. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiat 60(2): 141- 151.
79. Ursini G, Bollati V, Fazio L, Porcelli A, Iacovelli L, Catalani A, Sinibaldi L, Gelao B, Romano R, Rampino A, et al. 2011. Stress-related methylation of the catechol-o-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J Neurosci 31(18): 6692- 6698.
80. Whiteside SP, Lynam DR. 2001. The five factor model and impulsivity: Using a structural model of personality to understand impulsivity. Pers Indiv Differ 30: 669- 689.
81. Winterer G, Weinberger DR. 2004. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27(11): 683- 690.
82. Wray NR, James MR, Dumenil T, Handoko HY, Lind PA, Montgomery GW, Martin NG. 2008. Association study of candidate variants of COMT with neuroticism, anxiety and depression. Am J Med Genet B 147B(7): 1314- 1318.
83. Yacubian J, Sommer T, Schroeder K, Glascher J, Kalisch R, Leuenberger B, Braus DF, Buchel C. 2007. Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci USA 104(19): 8125- 8130.
84. Zalsman G, Huang YY, Oquendo MA, Brent DA, Giner L, Haghighi F, Burke AK, Ellis SP, Currier D, Mann JJ. 2008. No association of COMT Val158Met polymorphism with suicidal behavior or CSF monoamine metabolites in mood disorders. Arch Suicide Res 12(4): 327- 335.